Article Details
Retrieved on: 2024-12-10 16:45:29
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses research showing how GLP-1 peptide meds like Ozempic can reduce venous thromboembolism risk in diabetes patients. Tagged topics like peptide hormones and thromboembolism relate to this study, while COVID-19 isn't directly addressed.
Article found on: www.upi.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here